Medical Insights from Industry

RSS

"Insights from Industry" is a dynamic series of interviews at the cutting edge of the medical industry. Every interviewee is a leader in their particular field and is handpicked to give an informative and accessible insight into their chosen field. These interviews are guaranteed to keep you in the know in a rapidly changing industry.

What is pharmaceutical forecasting?

In this interview News Medical is talking to David James about pharmaceutical forecasting, J+D Forecasting solutions and their plans for the future.

From J+D Forecasting 13 Jan 2023

Clinically relevant biomarker strategies in drug development

In this interview, NewsMedical speaks with Dr. Justin Devine and Dr. Nicholas Woudberg about biomarkers, their importance for drug development as well as the potential they have when it comes to machine learning.

From Synexa Life Sciences BV 9 Jan 2023

How Can Virtual Reality Aid Physical Therapy?

NewsMedical spoke with Kiki Coppelmans from InMotion VR about their Corpus virtual reality platform that offers innovative rehabilitative therapy solutions.

From Corpus VR 19 Dec 2022

Next-generation sequencing could change research on sexual assault cases

In this interview, Alexis Garloff talks to NewsMedical about her next-generation sequencing research and the possible applications in forensics, particularly in sexual assault cases.

From Verogen, Inc. 16 Dec 2022

Fraunhofer Presents Exciting Battery Innovations for the Medical Sector

At MEDICA 2022, NewsMedical spoke with Andreas Wuersig from Fraunhofer ISIT about the current and potential applications of their battery research and technology in the medical sector.

From MEDICA 15 Dec 2022

Using Whole Exome Sequencing and Carrier Screening Tests for Birth Defects

In this interview, NewsMedical speaks with Rainu Wau from International Maternal and Children’s Hospital, Shanghai, China, about her experience using whole exome sequencing and carrier screening tests.

From BGI Genomics 8 Dec 2022

Colorectal cancer doesn’t wait - DNA methylation tests facilitate earlier treatment

In this interview, Yantao Li and Zhe Wang, Director of Cancer Early Screening Products and the Product Director of Oncology at BGI Genomics, talks to NewsMedical about colorectal cancer (CRC), including why incidences are important and the importance of screening.

From BGI Genomics 6 Dec 2022

The Applications of Non-Invasive Prenatal Testing (NIPT) - 10 Years of Experience

In this interview, NewsMedical speaks with Iris Meng from Shanghai, China, about the application of non-invasive prenatal testing (NIPT).

From BGI Genomics 6 Dec 2022

The critical role of flow cytometry in CAR+ T-Cell trials

In this interview, Ryan Muise talks to AZoNetwork about the added value of using flow cytometry in CAR T-Cell clinical trials.

From Cerba Research 6 Dec 2022

Pre-Plated Assay Solutions That Can Help Accelerate Biotech

In this interview, we speak with University of Warwick spin-out Cryologyx about their innovative new technology that hopes to revolutionize cell-based assays for researchers across life sciences and drug discovery.

From Cryologyx Ltd 6 Dec 2022

The importance of early cancer screening

In this interview, Thomas Qiu, Senior Product Manager from BGI Genomics, talks to NewsMedical about current global cancer rates, and the importance of early cancer screening.

From BGI Genomics 1 Dec 2022

Embracing Robotic Assistance in Neurorehabilitation

NewsMedical spoke to Waduda Parolari Musaid at MEDICA 2022 about Gloreha's robotics-assisted neurorehabilitation solutions. The robotic device and associated on-screen software suite aim to make hand movement recovery quicker and easier for patients.

From Gloreha 1 Dec 2022

The effects of mechanical forces on musculoskeletal cells and tissues

In this interview, Dr. Marina Danalache, Lab leader at the Laboratory of Cell Biology, Department of Orthopedic Surgery, University of Tübingen talks to News-Medical Life Sciences about the ongoing research on the effects of mechanical forces on musculoskeletal cells and tissues, as well as how these forces mediate homeostasis and drive pathophysiological processes.

From Bruker BioAFM 30 Nov 2022

Pioneering new medical imaging solutions

In this interview, News-Medical talks to Allen Lee from American Portwell Technology, about their work for the company and how they have become a leading provider of medical equipment and medical imaging equipment in particular.

From American Portwell Technology, Inc 29 Nov 2022

Pioneering new medical imaging solutions

From American Portwell Technology, Inc 29 Nov 2022

Realistic 3D-Printed Thoracic Models for Surgical Training

At MEDICA 2022, NewsMedical spoke with Heike and Thorsen Walles, founders of MD2B LifeScience, which provides realistic thorax models for surgical and implant training. These 3D-printed models could revolutionize how training is approached, with replaceable ribs that replicate the behavior of actual human bones.

From MD2B Life Science GmbH 28 Nov 2022

How Can CPNs Revolutionize Medical Diagnostics?

At MEDICA 2022, NewsMedical spoke with Andy Chaloner about Stream Bio's conjugated polymer nanoparticle technologies that have the potential to revolutionize the medical and life sciences sectors, from diagnostics to clinical imaging.

From Stream Bio 25 Nov 2022

Behind the Scenes of the Oncology & Precision Medicine Conferences 2022

During the conference, we caught up with some of the speakers to learn more about their work, what they were presenting, and their thoughts about the future of Oncology and Precision Medicine.

15 Nov 2022

Harnessing the natural potential of venom for drug discovery

Steven Trim, Founder and Cheif Scientific Officer at Venomtech, tells NewsMedical how UK-based Venomtech® harnesses the power of naturally-produced venoms obtained from a collection of nearly 200 species of spiders, scorpions, and centipedes to create compound libraries for drug discovery.

From INTEGRA Biosciences 14 Nov 2022

What is Proactive PMS and How You Can Ensure Compliance?

This interview with Dr. Amie Smirthwaite, Senior Vice President, Intelligence and Innovation at RQM+, discusses proactive post-market surveillance (PMS) and how you can ensure compliance under EU MDR and IVDR.

From RQM+ 10 Nov 2022